
H. Lundbeck A/S - Company Profile and SWOT Analysis
Description
H. Lundbeck A/S - Company Profile and SWOT Analysis
Summary
H. Lundbeck A/S - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
H. Lundbeck A/S (Lundbeck or 'the company') is engaged in research, development, production and sale of pharmaceuticals mainly concentrating on central nervous system (CNS) disorders. The company's products are focused on treating depression/anxiety, Alzheimer's disease, schizophrenia, alcohol dependence, Parkinson's disease, epilepsy, Lennox-gastaut syndrome, Huntington's disease, psychotic disorders, symptomatic neurogenic orthostatic hypotension, and bipolar disorders. Lundbeck markets its products under Abilify Maintena, Azilect, Brintellix, Celexa, Cipralex, Cipramil, Cisordinol, Deanxit, Ebixa, Lexapro, Northera, Onfi, Rexulti, Sabril, Trintellix, and Xenazine brands names. Its largest markets are Australia, China, Brazil, US, Spain, South Korea, Italy, Canada, Japan, and France. Lundbeck sells its products to distributors of pharmaceuticals, hospitals and pharmacies. The company is headquartered in Valby, Denmark.
Scope
Summary
H. Lundbeck A/S - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
H. Lundbeck A/S (Lundbeck or 'the company') is engaged in research, development, production and sale of pharmaceuticals mainly concentrating on central nervous system (CNS) disorders. The company's products are focused on treating depression/anxiety, Alzheimer's disease, schizophrenia, alcohol dependence, Parkinson's disease, epilepsy, Lennox-gastaut syndrome, Huntington's disease, psychotic disorders, symptomatic neurogenic orthostatic hypotension, and bipolar disorders. Lundbeck markets its products under Abilify Maintena, Azilect, Brintellix, Celexa, Cipralex, Cipramil, Cisordinol, Deanxit, Ebixa, Lexapro, Northera, Onfi, Rexulti, Sabril, Trintellix, and Xenazine brands names. Its largest markets are Australia, China, Brazil, US, Spain, South Korea, Italy, Canada, Japan, and France. Lundbeck sells its products to distributors of pharmaceuticals, hospitals and pharmacies. The company is headquartered in Valby, Denmark.
Scope
- Detailed information on H. Lundbeck A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting H. Lundbeck A/S in the form of a SWOT analysis
- An in-depth view of the business model of H. Lundbeck A/S including a breakdown and examination of key business segments
- Intelligence on H. Lundbeck A/S's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about H. Lundbeck A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of H. Lundbeck A/S and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess H. Lundbeck A/S as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on H. Lundbeck A/S's business structure, strategy and prospects.
Table of Contents
41 Pages
- Company Snapshot
- H. Lundbeck A/S: Company Overview
- H. Lundbeck A/S: Overview and Key Facts
- H. Lundbeck A/S: Overview
- H. Lundbeck A/S: Key Facts
- H. Lundbeck A/S: Key Employees
- H. Lundbeck A/S: Key Employee Biographies
- H. Lundbeck A/S: Major Products and Services
- H. Lundbeck A/S: Management Statement
- H. Lundbeck A/S: Locations and Subsidiaries
- H. Lundbeck A/S: Key Competitors
- H. Lundbeck A/S: Company Analysis
- H. Lundbeck A/S: Business Description
- H. Lundbeck A/S: SWOT Analysis
- H. Lundbeck A/S: SWOT Overview
- H. Lundbeck A/S: Strengths
- H. Lundbeck A/S: Weaknesses
- H. Lundbeck A/S: Opportunities
- H. Lundbeck A/S: Threats
- H. Lundbeck A/S: Corporate Financial Deals Activity
- H. Lundbeck A/S: Financial Deals Overview
- H. Lundbeck A/S: Targets and Partners
- H. Lundbeck A/S: Top Deals 2021 - 2025YTD*
- H. Lundbeck A/S: Advisors
- H. Lundbeck A/S: Top Legal Advisors
- H. Lundbeck A/S: Top Financial Advisors
- H. Lundbeck A/S: Mergers and Acquisitions
- H. Lundbeck A/S: Partnership
- H. Lundbeck A/S: Recent Developments
- H. Lundbeck A/S: News and Events Summary
- H. Lundbeck A/S: Contracts
- H. Lundbeck A/S: Corporate Governance
- H. Lundbeck A/S: Financial Deals
- H. Lundbeck A/S: Financial Performance
- H. Lundbeck A/S: Research & Development
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: H. Lundbeck A/S: Key Facts
- Table 2: H. Lundbeck A/S: Key Employees
- Table 3: H. Lundbeck A/S: Locations and Subsidiaries
- Table 4: H. Lundbeck A/S: Key Competitors
- Table 5: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: H. Lundbeck A/S: M&A Activity by Geography (TTM*)
- Table 7: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
- Table 8: H. Lundbeck A/S: M&A Average Deal Size - Value (US$m)
- Table 9: H. Lundbeck A/S: Targets and Partners
- Table 10: H. Lundbeck A/S: Top Deals 2021 - 2025YTD*
- Table 11: H. Lundbeck A/S: Legal Advisor Ranking by Value (US$m)
- Table 12: H. Lundbeck A/S: Financial Advisor Ranking by Value (US$m)
- Table 13: H. Lundbeck A/S: M&A Volume and Value Trend (2021 - YTD*2025)
- Table 14: H. Lundbeck A/S: M&A Activity by Geography (2021 - YTD*2025)
- Table 15: H. Lundbeck A/S: Partnership Volume and Value Trend (2021 - YTD*2025)
- Table 16: H. Lundbeck A/S: Partnership Trend by Deal Type (2021 - YTD*2025)
- Table 17: H. Lundbeck A/S: News and Events Summary
- Table 18: H. Lundbeck A/S: Contracts
- Table 19: H. Lundbeck A/S: Corporate Governance
- Table 20: H. Lundbeck A/S: Financial Deals
- Table 21: H. Lundbeck A/S: Financial Performance
- Table 22: H. Lundbeck A/S: Research & Development
- List of Figures
- Figure 1: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: H. Lundbeck A/S: M&A Activity by Geography (TTM*)
- Figure 3: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
- Figure 4: H. Lundbeck A/S: M&A Average Deal Size - Value (US$m)
- Figure 5: H. Lundbeck A/S: M&A Volume and Value Trend (2021 - YTD*2025)
- Figure 6: H. Lundbeck A/S: M&A Activity by Geography (2021 - YTD*2025)
- Figure 7: H. Lundbeck A/S: Partnership Volume and Value Trend (2021 - YTD*2025)
- Figure 8: H. Lundbeck A/S: Partnership Trend by Deal Type (2021 - YTD*2025)
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.